Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Randomized trial of daily high-dose vitamin D 3 in patients with RRMS receiving subcutaneous interferon β-1a
Raymond Hupperts, Joost Smolders, Reinhold Vieth, et al.
Neurology (2019) Vol. 93, Iss. 20
Open Access | Times Cited: 110

Showing 1-25 of 110 citing articles:

Vitamin D and Immune Regulation: Antibacterial, Antiviral, Anti‐Inflammatory
Emma L. Bishop, Aiten Ismailova, Sarah Dimeloe, et al.
JBMR Plus (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 274
Vitamin D and neurodegenerative diseases
Weixia Wang, Yijin Li, Xianfang Meng
Heliyon (2023) Vol. 9, Iss. 1, pp. e12877-e12877
Open Access | Times Cited: 53
Vitamin D Supplementation in Multiple Sclerosis: A Critical Analysis of Potentials and Threats
Julia Feige, Tobias Moser, Lara Bieler, et al.
Nutrients (2020) Vol. 12, Iss. 3, pp. 783-783
Open Access | Times Cited: 111
The role of vitamin D in autoimmune diseases: could sex make the difference?
Maria Luisa Dupuis, Maria Pagano, Marina Pierdominici, et al.
Biology of Sex Differences (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 86
An Update on Vitamin D and Disease Activity in Multiple Sclerosis
Joost Smolders, Øivind Torkildsen, William Camu, et al.
CNS Drugs (2019) Vol. 33, Iss. 12, pp. 1187-1199
Open Access | Times Cited: 80
A Brief Review of the Effects of Vitamin D on Multiple Sclerosis
Andrei Miclea, Maud Bagnoud, Andrew Chan, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 70
Full spectrum of vitamin D immunomodulation in multiple sclerosis: mechanisms and therapeutic implications
Manon Galoppin, Saniya Kari, Sasha Soldati, et al.
Brain Communications (2022) Vol. 4, Iss. 4
Open Access | Times Cited: 46
How Does Vitamin D Affect Immune Cells Crosstalk in Autoimmune Diseases?
Daniela Gallo, Denisa Baci, Nataša Kuštrimović, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4689-4689
Open Access | Times Cited: 37
Blood–brain barrier dysfunction in multiple sclerosis: causes, consequences, and potential effects of therapies
Bettina Zierfuss, Catherine Larochelle, Alexandre Prat
The Lancet Neurology (2023) Vol. 23, Iss. 1, pp. 95-109
Closed Access | Times Cited: 29
The Role of Vitamin D in Neuroprotection in Multiple Sclerosis: An Update
Amarpreet Sangha, Michaela Quon, Gerald Pfeffer, et al.
Nutrients (2023) Vol. 15, Iss. 13, pp. 2978-2978
Open Access | Times Cited: 28
High-dose vitamin D3 supplementation in relapsing-remitting multiple sclerosis: a randomised clinical trial
Sandra D. Cassard, Kathryn C. Fitzgerald, Peiqing Qian, et al.
EClinicalMedicine (2023) Vol. 59, pp. 101957-101957
Open Access | Times Cited: 26
Molecular insights into the pathogenic impact of vitamin D deficiency in neurological disorders
Md Jamir Anwar, Sattam Khulaif Alenezi, Ahmad Alhowail
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114718-114718
Open Access | Times Cited: 23
Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity
Patrick Ostkamp, Anke Salmen, Béatrice Pignolet, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 118, Iss. 1
Open Access | Times Cited: 60
Hygiene hypothesis and autoimmune diseases: A narrative review of clinical evidences and mechanisms
Giuseppe Murdaca, Mónica Greco, Matteo Borro, et al.
Autoimmunity Reviews (2021) Vol. 20, Iss. 7, pp. 102845-102845
Closed Access | Times Cited: 52
Progress in the Application of Drugs for the Treatment of Multiple Sclerosis
Weipeng Wei, Denglei Ma, Lin Li, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 41
Vitamins D2 and D3 Have Overlapping But Different Effects on the Human Immune System Revealed Through Analysis of the Blood Transcriptome
Louise R. Durrant, Giselda Bucca, Andrew Hesketh, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 37
Vitamin D in Neurological Diseases
Domenico Plantone, Guido Primiano, Carlo Manco, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 87-87
Open Access | Times Cited: 36
Vitamin D as a Risk Factor for Multiple Sclerosis: Immunoregulatory or Neuroprotective?
Sara E. Gombash, Priscilla W. Lee, Elizabeth Sawdai, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 35
Effects of Vitamin D and Body Mass Index on Disease Risk and Relapse Hazard in Multiple Sclerosis
Marijne Vandebergh, Bénédicte Dubois, An Goris
Neurology Neuroimmunology & Neuroinflammation (2022) Vol. 9, Iss. 3
Open Access | Times Cited: 31
High-dose vitamin D supplementation in multiple sclerosis – results from the randomized EVIDIMS (efficacy of vitamin D supplementation in multiple sclerosis) trial
Jan Dörr, Priscilla Bäcker-Koduah, Klaus–Dieter Wernecke, et al.
Multiple Sclerosis Journal - Experimental Translational and Clinical (2020) Vol. 6, Iss. 1, pp. 205521732090347-205521732090347
Open Access | Times Cited: 41
Environmental risk factors in multiple sclerosis: bridging Mendelian randomization and observational studies
Marijne Vandebergh, Nicolas Degryse, Bénédicte Dubois, et al.
Journal of Neurology (2022) Vol. 269, Iss. 8, pp. 4565-4574
Closed Access | Times Cited: 25
Vitamin D did not reduce multiple sclerosis disease activity after a clinically isolated syndrome
Helmut Butzkueven, Anne‐Louise Ponsonby, Mark S. Stein, et al.
Brain (2023) Vol. 147, Iss. 4, pp. 1206-1215
Open Access | Times Cited: 13
Vitamin D3 as an add-on treatment for multiple sclerosis: A systematic review and meta-analysis of randomized controlled trials
João Vitor Mahler, Marina Solti, Samira Luísa Apóstolos‐Pereira, et al.
Multiple Sclerosis and Related Disorders (2024) Vol. 82, pp. 105433-105433
Closed Access | Times Cited: 5
Transcriptomics identifies blunted immunomodulatory effects of vitamin D in people with multiple sclerosis
Wei Zhen Yeh, Rod A. Lea, Jim Stankovich, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Vitamin D affects the risk of disease activity in multiple sclerosis
Antonino Giordano, Ferdinando Clarelli, Béatrice Pignolet, et al.
Journal of Neurology Neurosurgery & Psychiatry (2024), pp. jnnp-334062
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top